Chitosan Nanoparticles as a New Delivery System for the Anti-HIV Drug Zidovudine

다국어 초록 (Multilingual Abstract)

Chitosan-based nanoparticles (CSNP) were prepared through ionic cross-linking and gelation of chitosan (CS) by tripolyphosphate (TPP). CS properties such as molecular weight, and preparation conditions were screened and the resulting nanoparticles were examined by Fourier transform infrared spectroscopy (FTIR), scanning electron microscopy (SEM) and transmission electron microscopy (TEM). The obtained particles were consistently spherical with an overall diameter of approximately 107 ± 20 nm. They were successfully used as a carrier for Zidovudine, an anti-human immunodeficiency virus (HIV) which, to our knowledge, is novel. The encapsulation ability, loading capacity, and controlled release behavior for these CSNP was evaluated. Results indicated that their intrinsic properties were strongly affected by properties inherent to CS such as molecular weight, and by the preparation condition, such as cross-linking density, which depends on the concentration of the cross-linker. In vitro release tests for the entrapped zidovudine showed that the CNNP provided a continuous release that can last upwards 20 h.

참고문헌 (Reference)

1 Broder, S., 113 : 604-, 1990

2 Xu, Y, 250 : 215-, 2003

3 Klecker, R. W., 41 : 407-, 1987

4 Wannachaiyasit, S, 9 : 840-, 2008

5 Knaul, J. Z, 72 : 1721-, 1999

6 Duarte, M. L., 31 : 1-, 2002

7 Huang, H, 5 : 2340-, 2004

8 Gan, Q, 44 : 65-, 2005

9 Yarchoan, R, 327 : 575-, 1986

10 Palombo, M. S, 19 : 3-, 2009

11 Shahiwala, A, 1 : 49-, 2007

12 Vyas, T. K, 3 : 613-, 2006

13 Bajaj, A, 38 : 12-, 2006

14 Hans, M. L., 6 : 319-, 2002

15 Soppimath, K. S., 70 : 1-, 2001

16 Felt, O, 24 : 979-, 1998

17 Rinaudo, M, 31 : 603-, 2006

18 Kean, T, 62 : 3-, 2010

19 He, P, 166 : 75-, 1998

20 Lehr, C. M, 78 : 43-, 1992

21 Porporatto, C, 78 : 62-, 2005

22 Van der Lubben, I. M, 22 : 687-, 2001

23 Yamamoto, H, 102 : 373-, 2005

24 Agnihotri, S. A, 100 : 5-, 2004

25 Prabaharan, M, 12 : 41-, 2004

26 Ciofani, G, 10 : 131-, 2008

27 De Campos, A. M, 224 : 159-, 2001

28 Dube, A, 41 : 219-, 2010

29 Huang, X, 76 : 368-, 2009

30 Janes, K. A, 73 : 255-, 2001

31 Katas, H, 115 : 216-, 2006

32 Mitra, S., 74 : 317-, 2001

33 Wilson, B., 6 : 144-, 2010

34 Rhazi, M, 49 : 337-, 2000

35 Rinaudo, M, 15 : 281-, 1993

36 Banerjee, T.;, 243 : 93-, 2002

37 Dudhani, A. R, 81 : 243-, 2010

38 Paul, W, "STP Pharma" 10 : 5-, 2000

39 Mitsuya, H., "R. ; Broder" 1533-, 1990

40 Tolaimate, A, "P. Polymer. 2000" 41 : 2463-, 2000

41 Broussignac, P, "Chimie Industrielle et Genie Chimique" 99 : 1241-, 1968

42 Lavertu, M, "A. Journal of Pharmaceutical and Biomedical Analysis 2003" 32 : 1149-, 2003

43 Kumar, M. N. V. R, "A. J. Chem. Rev. 2004" 104 : 6017-, 2004